For the year ending 2025-12-31, QSI had -$27,602K decrease in cash & cash equivalents over the period. -$97,234K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -101,339 |
| Depreciation and amortization | 4,454 |
| Allowance for credit losses | 146 |
| Non-cash lease expense | 2,309 |
| Loss on lease termination | 2,260 |
| Write-off of construction on process due to lease termination | 1,162 |
| Unrealized gain on trading securities, net | 0 |
| Realized loss on trading securities | 0 |
| Accretion on marketable securities | 8,022 |
| Loss on disposal of fixed assets | -31 |
| Write-down of inventory | 2,290 |
| Change in fair value of warrant liabilities | -4,202 |
| Change in fair value of contingent consideration | 0 |
| Stock-based compensation | 10,773 |
| Other | 1 |
| Accounts receivable, net | -626 |
| Legal settlement insurance receivable | 4,638 |
| Inventory | 2,006 |
| Prepaid expenses and other current assets | 1,563 |
| Operating lease right-of-use assets | 0 |
| Other assets | -3 |
| Accounts payable | -338 |
| Accrued expenses and other current liabilities | -1,495 |
| Accrued legal settlement liability | 8,000 |
| Other long-term liabilities | 14 |
| Operating lease liabilities | -3,181 |
| Net cash used in operating activities | -94,717 |
| Purchases of property and equipment | 2,517 |
| Internally developed software - capitalized costs | 0 |
| Purchases of marketable securities | 404,581 |
| Sales and maturities of marketable securities | 378,778 |
| Net cash (used in) provided by investing activities | -28,320 |
| Proceeds from exercise of stock options | 1,912 |
| Proceeds from vesting of restricted stock | 1 |
| Proceeds from issuance of common stock from direct equity offerings and the exercise of public and pre-funded warrants, net of fees and issuance costs | 93,510 |
| Proceeds from issuance of common stock from at-the-market offering, net of commissions and issuance costs | 0 |
| Deferred offering costs | 0 |
| Refund of issuance costs | 0 |
| Net cash provided by financing activities | 95,423 |
| Effect of exchange rate changes on cash and cash equivalents | 12 |
| Net (decrease) increase in cash and cash equivalents | -27,602 |
| Cash and cash equivalents at beginning of period | 49,241 |
| Cash and cash equivalents at end of period | 21,639 |
Quantum-Si Inc (QSI)
Quantum-Si Inc (QSI)